In vivo differentiation of adenoma and carcinoma in CRC progression by PAR2-M/DiD ratiometric fluorescence and its microstructures

[1]  Juyoung Yoon,et al.  Fluorescent probes for the detection of disease-associated biomarkers. , 2022, Science bulletin.

[2]  Pengfei Xu,et al.  Global colorectal cancer burden in 2020 and projections to 2040 , 2021, Translational oncology.

[3]  Yongfei Li,et al.  Construction of NIR and Ratiometric Fluorescent Probe for Monitoring Carbon Monoxide under Oxidative Stress in Zebrafish. , 2021, Analytical chemistry.

[4]  M. Wallace,et al.  Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial. , 2020, Gastroenterology.

[5]  Zhiyong Guo,et al.  Single Wavelength Laser Excitation Ratiometric NIR-II Fluorescent Probe for Molecule Imaging in Vivo. , 2020, Analytical chemistry.

[6]  A. Jemal,et al.  Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[7]  A. Abadir,et al.  Artificial Intelligence in Gastrointestinal Endoscopy , 2020, Clinical endoscopy.

[8]  C. Tomuschat,et al.  Increased protease activated receptors in the colon of patients with Hirschsprung's disease. , 2019, Journal of pediatric surgery.

[9]  Thomas D. Wang,et al.  Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet , 2019, Scientific Reports.

[10]  Chaohui Wang,et al.  PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis. , 2019, Cancer letters.

[11]  Zhen Cheng,et al.  NIR‐II Fluorescence Endoscopy for Targeted Imaging of Colorectal Cancer , 2019, Advanced healthcare materials.

[12]  A. Nagahara,et al.  Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma , 2019, Journal of gastroenterology and hepatology.

[13]  E. Giovannucci,et al.  Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.

[14]  T. Takayama,et al.  Epidermal growth factor receptor‐targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models , 2019, Cancer science.

[15]  Feng Xu,et al.  Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. , 2019, Gene.

[16]  A. Nagahara,et al.  Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma , 2018, World journal of gastroenterology.

[17]  Yueqing Gu,et al.  A novel near‐infrared fluorescent probe for monitoring cyclooxygenase‐2 in inflammation and tumor , 2018, Journal of biophotonics.

[18]  V. Ntziachristos,et al.  Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy , 2018, Theranostics.

[19]  H. Tian,et al.  Lightening Up Membrane Receptors with Fluorescent Molecular Probes and Supramolecular Materials , 2017 .

[20]  Xiaolan Chen,et al.  A ratiometric fluorescent probe for hypochlorous acid determination: Excitation and the dual-emission wavelengths at NIR region. , 2017, Talanta.

[21]  David Lieberman,et al.  Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.

[22]  H. Tian,et al.  Fluorogenic 2D Peptidosheet Unravels CD47 as a Potential Biomarker for Profiling Hepatocellular Carcinoma and Cholangiocarcinoma Tissues , 2017, Advanced materials.

[23]  Tri M Phan,et al.  Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1 , 2016, Cancer Prevention Research.

[24]  A. Barrett,et al.  Fast-Track Zika Vaccine Development - Is It Possible? , 2016, The New England journal of medicine.

[25]  Siavash Yazdanfar,et al.  Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met , 2015, Nature Medicine.

[26]  Thomas D. Wang,et al.  Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results , 2013, Science Translational Medicine.

[27]  M. Trauner,et al.  Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement , 2013, Endoscopy.

[28]  M. Hollenberg,et al.  Structure, function and pathophysiology of protease activated receptors. , 2011, Pharmacology & therapeutics.

[29]  A. Bohm,et al.  Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins , 2011, Proceedings of the National Academy of Sciences.

[30]  W. Ruf,et al.  Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Hollenberg,et al.  2-Furoyl-LIGRLO-amide: A Potent and Selective Proteinase-Activated Receptor 2 Agonist , 2004, Journal of Pharmacology and Experimental Therapeutics.

[32]  J. Bond,et al.  Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. , 2000, Seminars in gastrointestinal disease.

[33]  J. Davis,et al.  Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[34]  Geoffrey E. Hinton,et al.  Deep Learning , 2015 .

[35]  A. Zauber,et al.  The advanced adenoma as the primary target of screening. , 2002, Gastrointestinal endoscopy clinics of North America.

[36]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.